Sunshine Biopharma Inc.
Public company- Headquarters
- FORT LAUDERDALE, Florida
- Ticker
- SBFM
- CIK
- 0001402328
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Aug 28, 2026
Executive appointmentdirector appointed: Andrew Keller
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorAndrew Keller | Aug 28, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Polomar Health Services, Inc.
director departs: Alexandra Peterson
- Alaunos Therapeutics, Inc.
director appointed: Peter Harwin
- Inhibitor Therapeutics, Inc.
Director appointed: Francis E. O’Donnell
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Executive appointment
director appointed: Andrew Keller
Andrew Keller was named director of Sunshine Biopharma Inc.. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 28, 2026Role: director
Only one public record so far. We add events as soon as a new filing lands; watch Sunshine Biopharma Inc. to get them in your digest.
Last verified Nov 8, 2026